Evidence map›Paper›PMID 26432597›Full record

ArticleJournal of autoimmunity2016

Targeting downstream transcription factors and epigenetic modifications following Toll-like receptor 7/8 ligation to forestall tissue injury in anti-Ro60 associated heart block.

Robert M Clancy, Androo J Markham, Joanne H Reed, Miroslav Blumenberg, Marc K Halushka, Jill P Buyon

Abstract read
In one paragraph

Article in Journal of autoimmunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Approaches towards fighting the COVID‑19 pandemic (Review).International journal of molecular medicine · 2021
    Review
  10. Review
  11. Common innate pathways to autoimmune disease.Clinical immunology (Orlando, Fla.) · 2020
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Robert M ClancyNew York University School of Medicine, Department of Medicine, Division of Rheumatology, 550 First Avenue, New York, NY 10016, USA. Electronic address: bobdclancy@aol.com.
Androo J MarkhamNew York University School of Medicine, Department of Medicine, Division of Rheumatology, 550 First Avenue, New York, NY 10016, USA.
Joanne H ReedGarvan Institute of Medical Research, Darlinghurst, Sydney, NSW 2010, Australia.
Miroslav BlumenbergNew York University School of Medicine, Department of Medicine, Division of Rheumatology, 550 First Avenue, New York, NY 10016, USA.
Marc K HalushkaJohns Hopkins University School of Medicine, Departments of Pathology and Oncology, 600 N. Wolfe Street, Baltimore, MD 21287, USA.
Jill P BuyonNew York University School of Medicine, Department of Medicine, Division of Rheumatology, 550 First Avenue, New York, NY 10016, USA.
New York University · USGarvan Institute of Medical Research · AUJohns Hopkins Medicine · US

Funding

Maternal Autoantibodies: Pathogenesis of Neonatal LupusR37AR042455 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL P · 2008 to 2018
$4.0M
Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH)R01HD079951 · NICHD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL P · 2015 to 2019
$1.4M
Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH)R03HD069986 · NICHD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL P · 2012 to 2014
$249k
RESEARCH REGISTRY FOR NEONATAL LUPUS-264942220N01AR042220 · NIAMS · HOSPITAL FOR JOINT DISEASES ORTHO INST · 1994 to 2003
$148k
NIAMS NIH HHS 3R37AR042455-21S1NIAMS NIH HHS 3R37AR042455-21S2NIAMS NIH HHS N01 AR042220NIAMS NIH HHS N01-AR-4-2220NIAMS NIH HHS R37 AR042455NICHD NIH HHS 1 R01 HD079951-01A1NICHD NIH HHS R01 HD079951NICHD NIH HHS R03 HD069986
6 · The paper itself

Abstract

Based on the consistent demonstration of fibrosis of the atrioventricular node surrounded by macrophages and multinucleated giant cells in anti-Ro antibody exposed fetuses dying with heart block, this study focuses on macrophage signaling stimulated by ssRNA associated with the Ro60 protein and the impact of antagonizing innate cell drivers such as TLR7/8. Transcriptome and epigenetic modifications which affect transcription factors, NF-κB and STAT1, were selected to evaluate the phenotype of macrophages in which TLR7/8 was ligated following treatment with either anti-Ro60/Ro60/hY3 RNA immune complexes or transfection with hY3. Based on microarray, TNF and IL6 were among the most highly upregulated genes in both stimulated conditions, each of which was significantly inhibited by preincubation with hydroxychloroquine (HCQ). In contrast, following stimulation of macrophages with either TNF-α or IFN-α, which do not signal through TLR, the resultant gene expression was refractory to HCQ. Ligation of TLR7/8 resulted in increased histone methylation as measured by increased H3K4me2, a requirement for binding of NF-κB at certain promoters, specifically the kB1 region in the TNF promoter (ChIP-qPCR), which was significantly decreased by HCQ. In summary, these results support that the HCQ-sensitive phenotype of hY3 stimulated macrophages reflects the bifurcation of TLR downstream signals involving NF-κB and STAT 1 pathways and for the former dimethylation of H3K4. Accordingly, HCQ may act more as a preventive measure in downregulating the initial production of IFN-α or TNF-α and not affect the resultant autocoid stimulation reflected in TNF-α and IFN-α responsive genes. The beneficial scope of antimalarials in the prevention of organ damage, inclusive of heart block in an anti-Ro offspring or more broadly SLE, may include in part, a mechanism targeting TLR-dependent epigenetic modification.

Indexed as

Epigenesis, GeneticGene TargetingAntibodies, AntinuclearAntigen-Antibody ComplexCell LineEndocytosisGene ExpressionGene Knockdown TechniquesHeart BlockHistone Deacetylase 3Histone DeacetylasesHumansMacrophagesProtein BindingRibonucleoproteinsSS-A AntigenAntibodies, AntinuclearAntigen-Antibody ComplexHistone Deacetylase 3Histone DeacetylasesRibonucleoproteinsSS-A antibodiesSS-A AntigenToll-Like Receptor 7Toll-Like Receptor 8Transcription FactorsAnti-SSA/Ro autoantibodiesEpigeneticsInnate immunityMacrophagesToll-like receptor 7

Identifiers

PMID26432597
PMCPMC4752853
OpenAlexW1807434733

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.